UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000001298 |
|---|---|
| Receipt number | R000001577 |
| Scientific Title | Phase II study of exemestane with doxorubicin plus paclitaxel (AP) followed by weekly paclitaxel (wP) as primary systemic chemotherapy for hormone-sensitive and HER2-negative postmenopausal breast cancer (SBCCSG-13 EAPAC) |
| Date of disclosure of the study information | 2008/08/05 |
| Last modified on | 2018/12/18 19:55:59 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2008/08/04 23:21:30 | ||
| 2 | Update | 2009/01/06 20:49:19 | Recruitment status |
|
| 3 | Update | 2011/08/04 12:31:48 | Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
| 4 | Update | 2013/08/04 20:10:59 | Recruitment status Publication of results |
|
| 5 | Update | 2017/11/30 18:03:48 | UMIN ID1 |
|
| 6 | Update | 2018/12/18 19:55:59 | Recruitment status Date of protocol fixation Anticipated trial start date Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded |
